Stock Analysis on Net

Synopsys Inc. (NASDAQ:SNPS) 

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Synopsys Inc., consolidated cash flow statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020 Apr 30, 2020 Jan 31, 2020 Oct 31, 2019 Jul 31, 2019 Apr 30, 2019 Jan 31, 2019
Net income 1,095,620 404,894 289,089 446,207 346,495 333,055 269,948 268,627 151,557 219,646 293,892 313,341 201,137 198,392 194,802 162,028 196,555 252,911 109,920 104,061 160,714 99,929 118,210 153,514
Amortization and depreciation 114,916 56,263 60,998 62,888 67,087 63,111 59,628 57,294 58,697 57,746 50,277 61,685 52,402 51,208 49,438 50,628 50,830 54,078 52,846 52,232 49,543 49,292 51,011 51,830
Reduction of operating lease right-of-use assets 25,077 24,017 23,803 24,376 25,058 24,574 24,170 23,903 23,561 23,568 21,402 21,010 21,725 22,209 21,737 20,974 20,310 23,072 16,312 23,201
Amortization of capitalized costs to obtain revenue contracts 16,516 19,159 19,186 18,726 20,513 22,089 20,738 18,850 18,588 19,864 17,837 16,737 17,725 16,498 15,467 15,008 16,334 16,572 14,517 13,762 16,520 17,805 15,632 12,793
Stock-based compensation 152,290 181,539 177,835 180,652 141,343 144,464 143,258 134,227 125,592 127,605 110,061 95,771 96,742 85,162 79,586 83,782 78,429 61,837 56,435 51,883 40,175 39,452 36,914 38,460
Allowance for credit losses 5,028 4,709 3,928 6,059 7,995 5,803 2,434 3,700 1,039 (9,794) 5,278 4,702 3,762 2,574 7,477 6,000 4,893 5,121 4,861 2,719 5,000 2,450 1,500
Gain on sale of strategic investments (55,077)
Gain on divestitures, net of transaction costs (868,830)
Amortization of bridge financing costs 15,242 11,350 6,085 1,000
Deferred income taxes (130,809) (105,986) (69,522) (101,332) (44,984) (40,971) (59,595) (65,495) (42,756) (3,101) 20,896 (11,952) (95,467) (16,655) 3,761 (20,222) (37,152) (36,693) (19,987) (17,694) (72,956) 13,822 (17,271) (6,215)
Other non-cash 2,435 (1,123) (1,821) (786) 4,646 3,677 437 4,535 (168) 2,877 2,647 4,832 12,076 3,591 3,234 (3,042) 3,569 659 467 (370) (308) (3,744)
Accounts receivable (162,619) 38,270 140,460 (119,571) (290,943) 103,222 246,649 (237,360) (129,604) 47,999 296,899 (466,684) 12,710 31,359 172,547 (14,910) (147,139) (5,134) 161,831 (246,364) (97,945) 65,892 232,527 (209,049)
Inventories 19,854 (10,785) 365 (60,883) (45,833) (29,271) (40,038) (8,610) 1,202 (7,607) (1,430) 9,155 3,402 (13,143) (541) (37,764) (34,728) 4,941 (19,676) (5,561) 20,188 10,927 (34,531) (15,827)
Prepaid and other current assets (59,780) (159,057) (94,679) (96,916) (114,769) (41,064) 49,792 (355) (33,908) (53,658) (2,114) (303) (39,973) (16,229) (33,683) (12,289) 10,052 (15,461) (14,586) 8,697 (11,555) (19,677) (8,520) (10,027)
Other long-term assets (31,096) (32,608) (32,455) (72,096) 15,869 (41,163) (21,128) (54,196) 4,775 (11,357) 3,268 (11,969) (35,115) (20,403) (47,134) (50,385) (5,507) (39,482) (11,275) (27,103) (10,551) (23,073) (41,868) (49,403)
Accounts payable and accrued liabilities 170,032 159,618 124,618 (266,704) 121,922 211,414 (18,582) (144,258) 12,290 134,652 42,215 (223,223) 73,142 148,789 74,339 (171,137) 69,460 123,302 53,825 (132,814) 25,920 115,292 58,607 (219,099)
Operating lease liabilities (24,712) (23,545) (25,140) (23,569) (20,367) (21,280) (14,005) (17,629) (19,641) (22,224) (24,486) (19,477) (20,915) (20,561) (20,398) (20,707) (20,610) (25,536) (11,453) (20,979)
Income taxes 168,737 (12,416) (111,738) (117,798) 74,154 29,337 44,171 50,416 62,383 (26,493) (40,801) 6,555 58,269 (21,028) (20,612) 12,226 7,992 4,858 (3,769) 5,039 26,740 25,096 9,926 (41,985)
Deferred revenue 54,917 (98,888) (34,422) 87,034 17,875 (207,475) (4,937) 81,102 159,898 (69,823) (30,812) 354,988 7,997 (31,184) 31,221 152,291 (12,244) (25,394) (10,609) 196,969 71,737 (28,986) (66,523) 149,489
Net changes in operating assets and liabilities, net of acquired assets and assumed liabilities 135,333 (139,411) (32,991) (670,503) (242,092) 3,720 241,922 (330,890) 57,395 (8,511) 242,739 (350,958) 59,517 57,600 155,739 (142,675) (132,724) 22,094 144,288 (222,116) 24,534 145,471 149,618 (395,901)
Adjustments to reconcile net income to net cash provided by (used in) operating activities (532,802) 50,517 187,501 (533,997) (20,434) 226,467 432,992 (153,876) 241,948 220,048 456,065 (157,597) 169,422 223,375 331,536 11,930 5,596 146,512 269,999 (94,241) 60,535 270,534 234,610 (297,533)
Net cash provided by (used in) operating activities 562,818 455,411 476,590 (87,790) 326,061 559,522 702,940 114,751 393,505 439,694 749,957 155,744 370,559 421,767 526,338 173,958 202,151 399,423 379,919 9,820 221,249 370,463 352,820 (144,019)
Proceeds from maturities and sales of short-term investments 40,496 35,306 38,600 24,559 26,296 36,422 36,746 30,971 22,849 27,194 27,216 16,437 11,722 1,128
Purchases of short-term investments (39,640) (31,320) (40,249) (25,612) (28,622) (33,719) (39,909) (28,829) (23,915) (28,172) (27,948) (17,210) (15,650) (146,082)
Proceeds from sales of strategic investments 55,696 1,244 1,513 5,735 582 2,151 2,185 4,176
Purchases of strategic investments (53) (380) (38) (822) (435) (2,000) (5,000) (7,591) (262) (2,500) (3,245)
Purchases of property and equipment (4,389) (40,009) (38,372) (40,391) (53,098) (45,152) (47,868) (43,500) (33,655) (35,567) (25,616) (41,751) (26,807) (22,897) (16,281) (27,779) (34,483) (39,571) (26,058) (54,605) (75,771) (53,396) (39,955) (29,007)
Acquisitions, net of cash acquired (17,390) (71,730) (67,827) (246,368) (10,000) (41,324) (6,051) (307,263) (89,071) (19,989) (131,964) (89,427) 44 (74,670) (49,867) (75,790) (75,388) (36,605)
Proceeds from business divestiture, net of cash divested 1,446,578
Capitalization of software development costs (957) (623) (624) (523) (905) (571) (494) (459) (253) (253) (1,011) (1,010) (905) (1,065) (1,065) (2,014) (754) (754) (737)
Other (600) (600) (800)
Net cash (used in) provided by investing activities 1,442,992 (53,793) (111,789) (54,397) (300,548) (53,841) (91,465) (36,247) (41,295) (345,313) (117,990) (68,025) (163,158) (265,122) (17,290) (103,460) (35,493) (88,192) (103,175) (133,558) (117,635) (51,965) (36,533) (29,744)
Proceeds from credit facilities (1) 80,000 196,490 4,137 3,680 185,080
Repayment of debt (1,304) (1,303) (1,309) (1,294) (900) (75,938) (6,424) (8,443) (7,500) (5,694) (4,661) (105,781) (174,687) (3,750) (3,751) (153,750) (253,750) (112,812)
Payment of bridge financing and term loan costs (17,550) (6,715) (48,000)
Issuances of common stock 89,064 28,037 105,628 9,483 88,145 32,033 110,470 22,338 76,540 40,706 89,875 30,835 96,743 10,773 88,111 15,092 74,166 24,876 83,379 14,982 49,010 24,002 76,994 6,358
Payments for taxes related to net share settlement of equity awards (58,970) (65,994) (65,247) (147,330) (42,439) (82,131) (24,743) (92,095) (24,875) (48,004) (4,341) (96,785) (34,659) (49,627) (5,073) (49,591) (15,240) (49,880) (2,863) (14,242) (4,834) (39,136) (2,580) (10,593)
Purchase of equity forward contract (45,000) 40,000 (40,000) 40,000 (40,000) (35,000) 50,000 (50,000) 20,000 (20,000) 20,000 (20,000)
Purchases of treasury stock (300,000) (300,000) (300,000) (260,724) (382,734) (217,266) (290,000) (210,000) (214,999) (140,000) (195,211) (202,871) (42,078) (20,000) (100,000) (80,000) (120,000) (100,000) (80,000) (29,185)
Other (1,096) (122) (704) (2,709) (3,375) (1,000) (1,316) (762)
Net cash provided by (used in) financing activities 30,094 (56,811) 32,570 (187,150) (254,294) (351,407) (214,395) (376,775) (291,069) (266,168) (164,466) (394,597) (159,339) (225,672) (70,673) (293,064) 10,870 (130,785) (114,171) 93,480 (59,575) (264,747) (275,656) 38,086
Effect of exchange rate changes on cash, cash equivalents and restricted cash 3,339 3,035 (6,897) 9,320 (17,976) (12,711) (7,967) 35,675 (27,141) (18,200) (18,235) (1,720) (616) (3,472) (3,544) 10,001 8,454 13,124 (6,437) 2,013 (2,193) 1,882 (1,789) 4,882
Net change in cash, cash equivalents and restricted cash 2,039,243 347,842 390,474 (320,017) (246,757) 141,563 389,113 (262,596) 34,000 (189,987) 449,266 (308,598) 47,446 (72,499) 434,831 (212,565) 185,982 193,570 156,136 (28,245) 41,846 55,633 38,842 (130,795)

Based on: 10-K (reporting date: 2024-10-31), 10-Q (reporting date: 2024-07-31), 10-Q (reporting date: 2024-04-30), 10-Q (reporting date: 2024-01-31), 10-K (reporting date: 2023-10-31), 10-Q (reporting date: 2023-07-31), 10-Q (reporting date: 2023-04-30), 10-Q (reporting date: 2023-01-31), 10-K (reporting date: 2022-10-31), 10-Q (reporting date: 2022-07-31), 10-Q (reporting date: 2022-04-30), 10-Q (reporting date: 2022-01-31), 10-K (reporting date: 2021-10-31), 10-Q (reporting date: 2021-07-31), 10-Q (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-31), 10-K (reporting date: 2020-10-31), 10-Q (reporting date: 2020-07-31), 10-Q (reporting date: 2020-04-30), 10-Q (reporting date: 2020-01-31), 10-K (reporting date: 2019-10-31), 10-Q (reporting date: 2019-07-31), 10-Q (reporting date: 2019-04-30), 10-Q (reporting date: 2019-01-31).

Cash flow statement item Description The company
Net cash provided by (used in) operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Synopsys Inc. net cash provided by (used in) operating activities decreased from Q2 2024 to Q3 2024 but then increased from Q3 2024 to Q4 2024 exceeding Q2 2024 level.
Net cash (used in) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Synopsys Inc. net cash (used in) provided by investing activities increased from Q2 2024 to Q3 2024 and from Q3 2024 to Q4 2024.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Synopsys Inc. net cash provided by (used in) financing activities decreased from Q2 2024 to Q3 2024 but then increased from Q3 2024 to Q4 2024 not reaching Q2 2024 level.